These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36226000)

  • 1. Role of Botulinum Toxin in the Management of Topical Corticosteroid Induced Rosacea Like Dermatitis: A Case Report.
    Katoch S; Barua TN; Barua KN
    Indian Dermatol Online J; 2022; 13(3):395-397. PubMed ID: 36226000
    [No Abstract]   [Full Text] [Related]  

  • 2. Topical Steroid-Induced Perioral Dermatitis (TOP STRIPED): Case Report of a Man Who Developed Topical Steroid-Induced Rosacea-Like Dermatitis (TOP SIDE RED).
    Diehl KL; Cohen PR
    Cureus; 2021 Apr; 13(4):e14443. PubMed ID: 33996307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum Toxin: An Effective Treatment for Flushing and Persistent Erythema in Rosacea.
    Luque A; Rojas AP; Ortiz-Florez A; Perez-Bernal J
    J Clin Aesthet Dermatol; 2021 Mar; 14(3):42-45. PubMed ID: 33841616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilateral Morganella Morganii keratitis in a patient with facial topical corticosteroid-induced rosacea-like dermatitis: a case report.
    Zhang B; Pan F; Zhu K
    BMC Ophthalmol; 2017 Jun; 17(1):106. PubMed ID: 28659135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathogenetic role of rod-shaped bacteria containing intracellular granules in the vellus hairs of a patient with perioral dermatitis: A comparison with perioral corticosteroid-induced rosacea.
    Maeda A; Ishiguro N; Kawashima M
    Australas J Dermatol; 2016 Aug; 57(3):225-8. PubMed ID: 25894304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulsed dye laser followed by intradermal botulinum toxin type-A in the treatment of rosacea-associated erythema and flushing.
    Al-Niaimi F; Glagoleva E; Araviiskaia E
    Dermatol Ther; 2020 Nov; 33(6):e13976. PubMed ID: 32633449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical corticosteroid-induced rosacea-like dermatitis: a clinical study of 110 cases.
    Rathi SK; Kumrah L
    Indian J Dermatol Venereol Leprol; 2011; 77(1):42-6. PubMed ID: 21220878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Pilot Study to Evaluate the Efficacy and Safety of Treatment with Botulinum Toxin in Patients with Recalcitrant and Persistent Erythematotelangiectatic Rosacea.
    Park KY; Kwon HJ; Kim JM; Jeong GJ; Kim BJ; Seo SJ; Kim MN
    Ann Dermatol; 2018 Dec; 30(6):688-693. PubMed ID: 33911508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosacea-like eruption due to topical pimecrolimus.
    El-Heis S; Buckley DA
    Dermatol Online J; 2015 May; 21(5):. PubMed ID: 26295863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical corticosteroid 'addiction'. A cause of perioral dermatitis.
    Wells K; Brodell RT
    Postgrad Med; 1993 Apr; 93(5):225-30. PubMed ID: 8460079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Botulinum Toxin in Treating Rosacea: A Systematic Review.
    Zhang H; Tang K; Wang Y; Fang R; Sun Q
    Clin Cosmet Investig Dermatol; 2021; 14():407-417. PubMed ID: 33958886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The toxic edge-A novel treatment for refractory erythema and flushing of rosacea.
    Friedman O; Koren A; Niv R; Mehrabi JN; Artzi O
    Lasers Surg Med; 2019 Apr; 51(4):325-331. PubMed ID: 30311683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin for the treatment of refractory erythema and flushing of rosacea.
    Park KY; Hyun MY; Jeong SY; Kim BJ; Kim MN; Hong CK
    Dermatology; 2015; 230(4):299-301. PubMed ID: 25765295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on the management of rosacea.
    Weinkle AP; Doktor V; Emer J
    Clin Cosmet Investig Dermatol; 2015; 8():159-77. PubMed ID: 25897253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the Management of Rosacea.
    Weinkle AP; Doktor V; Emer J
    Plast Surg Nurs; 2015; 35(4):184-202. PubMed ID: 26605825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Willingness-to-Pay and Benefit-Cost Analysis of Botulinum Toxin for the Treatment of Rosacea in China: Findings from a Web-Based Survey.
    Yang X; Ouyang Y; Deng Y; Xiao Y; Tang Y; Jian D; Li J; Xie H; Huang Y
    Patient Prefer Adherence; 2021; 15():1197-1205. PubMed ID: 34113082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid-induced rosacea: a clinical study of 200 patients.
    Bhat YJ; Manzoor S; Qayoom S
    Indian J Dermatol; 2011 Jan; 56(1):30-2. PubMed ID: 21572787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facial dermatitis in a healthy 9-year-old boy.
    Hiep A; Gross E
    JAAPA; 2022 Sep; 35(9):37-40. PubMed ID: 36007117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbotox: A prospective evaluation of dermatological improvement in patients with mild-to-moderate acne and erythematotelangiectatic rosacea.
    Calvisi L; Diaspro A; Sito G
    J Cosmet Dermatol; 2022 Sep; 21(9):3747-3753. PubMed ID: 35312149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complications of topical hydrocortisone.
    Guin JD
    J Am Acad Dermatol; 1981 Apr; 4(4):417-22. PubMed ID: 6453138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.